Your browser doesn't support javascript.
loading
YAP promotes proliferation, chemoresistance, and angiogenesis in human cholangiocarcinoma through TEAD transcription factors.
Marti, Patricia; Stein, Claudia; Blumer, Tanja; Abraham, Yann; Dill, Michael T; Pikiolek, Monika; Orsini, Vanessa; Jurisic, Giorgia; Megel, Philippe; Makowska, Zuzanna; Agarinis, Claudia; Tornillo, Luigi; Bouwmeester, Tewis; Ruffner, Heinz; Bauer, Andreas; Parker, Christian N; Schmelzle, Tobias; Terracciano, Luigi M; Heim, Markus H; Tchorz, Jan S.
Afiliación
  • Marti P; Novartis Institutes for Biomedical Research, Developmental and Molecular Pathways, Novartis Pharma AG, Basel, Switzerland.
  • Stein C; Novartis Institutes for Biomedical Research, Developmental and Molecular Pathways, Novartis Pharma AG, Basel, Switzerland.
  • Blumer T; Division of Gastroenterology and Hepatology, University Hospital Basel, Basel, Switzerland.
  • Abraham Y; Novartis Institutes for Biomedical Research, Developmental and Molecular Pathways, Novartis Pharma AG, Basel, Switzerland.
  • Dill MT; Division of Gastroenterology and Hepatology, University Hospital Basel, Basel, Switzerland.
  • Pikiolek M; Novartis Institutes for Biomedical Research, Developmental and Molecular Pathways, Novartis Pharma AG, Basel, Switzerland.
  • Orsini V; Novartis Institutes for Biomedical Research, Developmental and Molecular Pathways, Novartis Pharma AG, Basel, Switzerland.
  • Jurisic G; Novartis Institutes for Biomedical Research, Developmental and Molecular Pathways, Novartis Pharma AG, Basel, Switzerland.
  • Megel P; Novartis Institutes for Biomedical Research, Oncology, Novartis Pharma AG, Basel, Switzerland.
  • Makowska Z; Division of Gastroenterology and Hepatology, University Hospital Basel, Basel, Switzerland.
  • Agarinis C; Novartis Institutes for Biomedical Research, Developmental and Molecular Pathways, Novartis Pharma AG, Basel, Switzerland.
  • Tornillo L; Institute for Pathology, University Hospital Basel, Basel, Switzerland.
  • Bouwmeester T; Novartis Institutes for Biomedical Research, Developmental and Molecular Pathways, Novartis Pharma AG, Basel, Switzerland.
  • Ruffner H; Novartis Institutes for Biomedical Research, Developmental and Molecular Pathways, Novartis Pharma AG, Basel, Switzerland.
  • Bauer A; Novartis Institutes for Biomedical Research, Developmental and Molecular Pathways, Novartis Pharma AG, Basel, Switzerland.
  • Parker CN; Novartis Institutes for Biomedical Research, Developmental and Molecular Pathways, Novartis Pharma AG, Basel, Switzerland.
  • Schmelzle T; Novartis Institutes for Biomedical Research, Oncology, Novartis Pharma AG, Basel, Switzerland.
  • Terracciano LM; Institute for Pathology, University Hospital Basel, Basel, Switzerland.
  • Heim MH; Division of Gastroenterology and Hepatology, University Hospital Basel, Basel, Switzerland.
  • Tchorz JS; Novartis Institutes for Biomedical Research, Developmental and Molecular Pathways, Novartis Pharma AG, Basel, Switzerland.
Hepatology ; 62(5): 1497-510, 2015 Nov.
Article en En | MEDLINE | ID: mdl-26173433

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Factores de Transcripción / Neoplasias de los Conductos Biliares / Conductos Biliares Intrahepáticos / Proteínas Nucleares / Colangiocarcinoma / Resistencia a Antineoplásicos / Proteínas de Unión al ADN / Neovascularización Patológica Límite: Animals / Female / Humans Idioma: En Revista: Hepatology Año: 2015 Tipo del documento: Article País de afiliación: Suiza

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Factores de Transcripción / Neoplasias de los Conductos Biliares / Conductos Biliares Intrahepáticos / Proteínas Nucleares / Colangiocarcinoma / Resistencia a Antineoplásicos / Proteínas de Unión al ADN / Neovascularización Patológica Límite: Animals / Female / Humans Idioma: En Revista: Hepatology Año: 2015 Tipo del documento: Article País de afiliación: Suiza